Advertisement

Topics

Thermo Fisher Expands Gene Therapy Business with $1.7 Billion Acquisition of Brammer Bio

11:23 EDT 26 Mar 2019 | Speciality Pharma Journal

WALTHAM, Mass. and CAMBRIDGE, Mass., March 24, 2019 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and Brammer Bio, a leader in viral vector manufacturing for gene and cell therapies, today announced they have entered into a definitive agreement under which Thermo Fisher will acquire Brammer Bio for approximately …

Original Article: Thermo Fisher Expands Gene Therapy Business with $1.7 Billion Acquisition of Brammer Bio

NEXT ARTICLE

More From BioPortfolio on "Thermo Fisher Expands Gene Therapy Business with $1.7 Billion Acquisition of Brammer Bio"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...